BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 26947776)

  • 1. Current Advances in Developing Inhibitors of Bacterial Multidrug Efflux Pumps.
    Mahmood HY; Jamshidi S; Sutton JM; Rahman KM
    Curr Med Chem; 2016; 23(10):1062-81. PubMed ID: 26947776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview of bacterial efflux pumps and computational approaches to study efflux pump inhibitors.
    Jamshidi S; Sutton JM; Rahman KM
    Future Med Chem; 2016; 8(2):195-210. PubMed ID: 26824720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efflux Pump Inhibitors: A Novel Approach to Combat Efflux-Mediated Drug Resistance in Bacteria.
    Wang Y; Venter H; Ma S
    Curr Drug Targets; 2016; 17(6):702-19. PubMed ID: 26424403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medicinal Chemistry Updates on Bacterial Efflux Pump Modulators.
    Durães F; Pinto M; Sousa E
    Curr Med Chem; 2018; 25(42):6030-6069. PubMed ID: 29424299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hydrophobic trap-the Achilles heel of RND efflux pumps.
    Aron Z; Opperman TJ
    Res Microbiol; 2018; 169(7-8):393-400. PubMed ID: 29146106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial multidrug efflux pumps: mechanisms, physiology and pharmacological exploitations.
    Sun J; Deng Z; Yan A
    Biochem Biophys Res Commun; 2014 Oct; 453(2):254-67. PubMed ID: 24878531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efflux pump inhibitors of clinically relevant multidrug resistant bacteria.
    Lamut A; Peterlin Mašič L; Kikelj D; Tomašič T
    Med Res Rev; 2019 Nov; 39(6):2460-2504. PubMed ID: 31004360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of Efflux Pump Inhibitors as Biofilm Disruptors and Resistance Breakers in Gram-Negative (ESKAPEE) Bacteria.
    Reza A; Sutton JM; Rahman KM
    Antibiotics (Basel); 2019 Nov; 8(4):. PubMed ID: 31752382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of multidrug resistant efflux systems in bacteria.
    Zechini B; Versace I
    Recent Pat Antiinfect Drug Discov; 2009 Jan; 4(1):37-50. PubMed ID: 19149695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Active efflux as the multidrug resistance mechanism].
    Wasaznik A; Grinholc M; Bielawski KP
    Postepy Hig Med Dosw (Online); 2009 Apr; 63():123-33. PubMed ID: 19373193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical impact of the over-expression of efflux pump in nonfermentative Gram-negative bacilli, development of efflux pump inhibitors.
    Vila J; Martínez JL
    Curr Drug Targets; 2008 Sep; 9(9):797-807. PubMed ID: 18781925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The development of efflux pump inhibitors to treat Gram-negative infections.
    Blanco P; Sanz-García F; Hernando-Amado S; Martínez JL; Alcalde-Rico M
    Expert Opin Drug Discov; 2018 Oct; 13(10):919-931. PubMed ID: 30198793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterial Multidrug Efflux Pumps of the Major Facilitator Superfamily as Targets for Modulation.
    Kumar S; He G; Kakarla P; Shrestha U; Ranjana KC; Ranaweera I; Willmon TM; Barr SR; Hernandez AJ; Varela MF
    Infect Disord Drug Targets; 2016; 16(1):28-43. PubMed ID: 27052334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryo-EM Structures of a Gonococcal Multidrug Efflux Pump Illuminate a Mechanism of Drug Recognition and Resistance.
    Lyu M; Moseng MA; Reimche JL; Holley CL; Dhulipala V; Su CC; Shafer WM; Yu EW
    mBio; 2020 May; 11(3):. PubMed ID: 32457251
    [No Abstract]   [Full Text] [Related]  

  • 15. A comprehensive review on pharmacology of efflux pumps and their inhibitors in antibiotic resistance.
    Thakur V; Uniyal A; Tiwari V
    Eur J Pharmacol; 2021 Jul; 903():174151. PubMed ID: 33964293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Silico Approach for Phytocompound-Based Drug Designing to Fight Efflux Pump-Mediated Multidrug-Resistant Mycobacterium tuberculosis.
    Biswas SS; Browne RB; Borah VV; Roy JD
    Appl Biochem Biotechnol; 2021 Jun; 193(6):1757-1779. PubMed ID: 33826064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidrug efflux pumps of Gram-positive bacteria.
    Schindler BD; Kaatz GW
    Drug Resist Updat; 2016 Jul; 27():1-13. PubMed ID: 27449594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Roads Leading to Old Destinations: Efflux Pumps as Targets to Reverse Multidrug Resistance in Bacteria.
    Spengler G; Kincses A; Gajdács M; Amaral L
    Molecules; 2017 Mar; 22(3):. PubMed ID: 28294992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efflux pumps in multidrug-resistant Acinetobacter baumannii: Current status and challenges in the discovery of efflux pumps inhibitors.
    Verma P; Tiwari M; Tiwari V
    Microb Pathog; 2021 Mar; 152():104766. PubMed ID: 33545327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An original deal for new molecule: reversal of efflux pump activity, a rational strategy to combat gram-negative resistant bacteria.
    Pagès JM; Amaral L; Fanning S
    Curr Med Chem; 2011; 18(19):2969-80. PubMed ID: 21651484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.